Drug Discovery and Chemical Biology Consortium

Drug Discovery and Chemical Biology Consortium (DDCB), Biocenter Finland-supported national research infrastructure for academic researchers in Finland, coordinates infrastructure and expertise in the areas of drug discovery and chemical biology, and makes it available to the scientific community. It is formed by the Institute for Molecular Medicine Finland, FIMM (University of Helsinki, UH), Biocenter Kuopio (University of Eastern Finland), Faculty of Pharmacy (UH), BioCity Turku (University of Turku and Åbo Academy University) and CSC – IT Center for Science. The chair of the DDCB consortium is Professor Päivi Tammela (UH).

 Find out more at: https://www.helsinki.fi/en/infrastructures/drug-discovery-and-chemical-biology-consortium